{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:23:21Z","timestamp":1787239401125,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s13346-025-01808-w","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T13:06:41Z","timestamp":1739452001000},"page":"3296-3306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A rifamycin SV in situ gelling formulation for the treatment of pouchitis"],"prefix":"10.1007","volume":"15","author":[{"given":"Katia","family":"Mangano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Quatrocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Ajello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2521-1336","authenticated-orcid":false,"given":"Gordon","family":"Alton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Gerloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"1808_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ibd.20278","volume":"14","author":"M Ferrante","year":"2008","unstructured":"Ferrante M, Declerck S, De Hertogh G, et al. Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Inflamm Bowel Dis. 2008;14:20\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"22","key":"1808_CR2","first-page":"00440","volume":"S1542\u20133565","author":"EL Barnes","year":"2022","unstructured":"Barnes EL, Allin K, Iversen AT, Herfarth HH, Jess T. Increasing incidence of Pouchitis between 1996 and 2018: a Population-based Danish cohort study. Clin Gastroenterol Hepatol. 2022;S1542\u20133565(22):00440\u20132.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1808_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1756283X10370611","volume":"3","author":"SD McLaughlin","year":"2010","unstructured":"McLaughlin SD, Clark SK, Tekkis PP, Nicholls RJ, Ciclitira PJ. The bacterial pathogenesis and treatment of pouchitis. Th Adv Gastroenterol. 2010;3(6):335\u201348.","journal-title":"Th Adv Gastroenterol"},{"issue":"8","key":"1808_CR4","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/apt.13780","volume":"44","author":"KM Schieffer","year":"2016","unstructured":"Schieffer KM, Williams ED, Yochum GS, Koltun WA. Review article: the pathogenesis of pouchitis. Aliment Pharmacol Ther. 2016;44(8):817\u201335.","journal-title":"Aliment Pharmacol Ther"},{"key":"1808_CR5","doi-asserted-by":"crossref","unstructured":"Rabbenou W, Chang S. Medical treatment of pouchitis: a guide for the clinician. Th Adv Gastroenterol. 2021; 14.","DOI":"10.1177\/17562848211023376"},{"key":"1808_CR6","doi-asserted-by":"crossref","unstructured":"Singh S, Stroud AM, Holubar SD, Sandborn WJ, Pardi DS. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Rev. 2015;(11):CD001176.","DOI":"10.1002\/14651858.CD001176.pub3"},{"issue":"1","key":"1808_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/MOG.0000000000000594","volume":"36","author":"H Shah","year":"2020","unstructured":"Shah H, Zezos P. Pouchitis: diagnosis and management. Curr Opin Gastroenterol. 2020;36(1):41\u20137.","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"1808_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/MEG.0000000000002362","volume":"34","author":"S Poo","year":"2022","unstructured":"Poo S, Sriranganathan D, Segal JP. Network meta-analysis: efficacy of treatment for acute, chronic, and prevention of pouchitis in ulcerative colitis. Eur J Gastroenterol Hepatol. 2022;34(5):518\u201328.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1808_CR9","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/ibd.20187","volume":"13","author":"KL Isaacs","year":"2007","unstructured":"Isaacs KL, Sandler RS, Abreu M, Picco MF, et al. Rifaximin for the treatment of active pouchitis: a Randomized, Double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007;13:1250\u20135.","journal-title":"Inflamm Bowel Dis"},{"key":"1808_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-230X-8-26","volume":"8","author":"B Shen","year":"2008","unstructured":"Shen B, Remzi FH, Lopez AR, Elaine Queener. Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. BMC Gastroenterol. 2008;8:26.","journal-title":"BMC Gastroenterol"},{"key":"1808_CR11","unstructured":"https:\/\/www.cosmopharma.com\/products\/aemcolo"},{"issue":"2","key":"1808_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijantimicag.2013.04.020","volume":"42","author":"C Rosette","year":"2013","unstructured":"Rosette C, Buendia-Laysa F, Patkar S, Moro L, Celasco G, Bozzella R, Ajani M, Gerloni M. Anti-inflammatory and immunomodulatory activities of rifamycin SV. Int J Antimicrob Agents. 2013;42(2):182\u20136.","journal-title":"Int J Antimicrob Agents"},{"key":"1808_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ejphar.2011.06.058","volume":"668","author":"A Mencarelli","year":"2011","unstructured":"Mencarelli A, Renga B, Palladion G, et al. Inhibition of NF-kappaB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells. Eur J Pharmacol. 2011;668:317\u201324.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1808_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.dmpk.2019.01.002","volume":"34","author":"C Rosette","year":"2019","unstructured":"Rosette C, Agan FJ, Rosette N, Moro L, Mazzetti A, Hassan C, Gerloni M. Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NF\u03baB inhibition. Drug Metab Pharmacokinet. 2019;34(3):172\u201380.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"1808_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00054725-200201000-00004","volume":"8","author":"KO Shebani","year":"2002","unstructured":"Shebani KO, Stucchi AF, et al. Pouchitis in a rat model of ileal J pouch-anal anastomosis. Inflam Bowel Dis. 2002;8(1):23\u201334.","journal-title":"Inflam Bowel Dis"},{"key":"1808_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00054725-200111000-00004","volume":"7","author":"B Shen","year":"2001","unstructured":"Shen B, Achkar JP, Lashner BA, et al. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis. 2001;7:301\u2013514.","journal-title":"Inflamm Bowel Dis"},{"key":"1808_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1046\/j.1365-2036.2002.01203.x","volume":"16","author":"T Mimura","year":"2002","unstructured":"Mimura T, Rizzello F, Helwig U, et al. Four week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractorypouchitis. Aliment Pharmacol Ther. 2002;16:909\u201317.","journal-title":"Aliment Pharmacol Ther"},{"key":"1808_CR18","first-page":"323","volume":"9","author":"B Shen","year":"2012","unstructured":"Shen B. Acute and chronic pouchitis pathogenesis, diagnosis, and treatment Nat. Rev Gastroenterol Hepatol. 2012;9:323\u201333.","journal-title":"Rev Gastroenterol Hepatol"},{"key":"1808_CR19","doi-asserted-by":"crossref","unstructured":"Nguyen N, Zhang B, Holubar SD, Pardi DS, Singh S. Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. Cochrane Database Syst Reviews 2019, Issue 5. Art. No.: CD001176.","DOI":"10.1002\/14651858.CD001176.pub4"},{"key":"1808_CR20","doi-asserted-by":"crossref","unstructured":"Ramadass SK, Perumal S, Jabaris SL, Madhan B. Preparation and evaluation of mesalamine collagen in situ rectal gel: A novel therapeutic approach for treating ulcerative colitis. European Journal of Pharmaceutical Sciences Volume 48, Issues 1\u20132, 23 January 2013, Pages 104\u2013110.","DOI":"10.1016\/j.ejps.2012.10.015"},{"issue":"3","key":"1808_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/pharmaceutics13030336","volume":"13","author":"F Al-Joufi","year":"2021","unstructured":"Al-Joufi F, Elmowafy M, Alruwaili NK, et al. Mucoadhesive in situ rectal gel loaded with rifampicin: strategy to improve bioavailability and alleviate liver toxicity. Pharmaceutics. 2021;13(3):336.","journal-title":"Pharmaceutics"},{"issue":"33","key":"1808_CR22","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.3748\/wjg.v23.i33.6016","volume":"23","author":"DD Eichele","year":"2017","unstructured":"Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol. 2017;23(33):6016\u201329.","journal-title":"World J Gastroenterol"},{"key":"1808_CR23","doi-asserted-by":"publisher","first-page":"pages235","DOI":"10.1007\/s00580-010-0979-4","volume":"19","author":"L Solomon","year":"2010","unstructured":"Solomon L, Mansor S, Mallon P, et al. The dextran sulphate sodium (DSS) model of colitis: an overview. Comp Clin Pathol Volume. 2010;19:pages235\u2013239.","journal-title":"Comp Clin Pathol Volume"},{"issue":"10","key":"1808_CR24","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1111\/bcp.14051","volume":"85","author":"S Bonovas","year":"2019","unstructured":"Bonovas S, Nikolopoulos GK, Piovani D, et al. Comparative assessment of budesonide-MMX and mesalamine in active, mild\u2010to\u2010moderate ulcerative colitis: a systematic review and network meta\u2010analysis. Br J Clin Pharmacol. 2019;85(10):2244\u201354.","journal-title":"Br J Clin Pharmacol"},{"key":"1808_CR25","doi-asserted-by":"crossref","unstructured":"Kim SH, Kwon D, Son SW et al. Inflammatory responses of C57BL\/6NKorl mice to dextran sulfate sodium-induced colitis: comparison between three C57BL\/6\u00a0N sub-strains. Laboratory Animal Research 37, 8 (2021).","DOI":"10.1186\/s42826-021-00084-2"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01808-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01808-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01808-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T05:00:52Z","timestamp":1757134852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01808-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1808"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01808-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"31 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Protection of animals used in the experiment is in accordance with Directive 2010\/63\/UE, enforced by the Italian Legislative Decree 26\/2014. Physical facilities and equipment for accommodation and care of animals are in accordance with the provisions of EEC Council Directive 86\/609. All authors read and approved the final manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors receive compensation in some form from Cosmo Pharmaceuticals or subsidiaries.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"competing interests"}}]}}